SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 258 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is 1.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,337,000 | +89.0% | 84,100 | +55.7% | 1.12% | +80.8% |
| Q3 2020 | $7,584,000 | -21.2% | 54,000 | -10.0% | 0.62% | -50.0% |
| Q2 2020 | $9,620,000 | +91.3% | 60,000 | +16.7% | 1.24% | +28.9% |
| Q1 2020 | $5,028,000 | -52.5% | 51,400 | -37.3% | 0.96% | -52.8% |
| Q4 2019 | $10,581,000 | -24.3% | 82,000 | -10.9% | 2.04% | -25.6% |
| Q2 2019 | $13,979,000 | +30.3% | 92,000 | +2.2% | 2.75% | +26.0% |
| Q1 2019 | $10,727,000 | +25.9% | 90,000 | +15.2% | 2.18% | -13.1% |
| Q4 2018 | $8,523,000 | -33.2% | 78,100 | -1.1% | 2.51% | +9.7% |
| Q3 2018 | $12,759,000 | +34.1% | 79,000 | +9.7% | 2.29% | +25.0% |
| Q2 2018 | $9,517,000 | +32.4% | 72,000 | -25.8% | 1.83% | -25.7% |
| Q1 2018 | $7,187,000 | +40.4% | 97,000 | +5.4% | 2.46% | +24.4% |
| Q4 2017 | $5,119,000 | +12.9% | 92,000 | -8.0% | 1.98% | +51.9% |
| Q3 2017 | $4,536,000 | – | 100,000 | – | 1.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |